Policy | September 14, 2023
Cabinet approves foreign investment of up to Rs. 9,589 crore in Suven Pharmaceuticals
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The approval is for acquisition of up to 76.1% equity shares of Suven Pharmaceuticals by Berhyanda Limited
The VitalDose Drug Delivery Platform has been used in patient-centric dose forms in women’s health for over two decades
These plant locations include Ramagundam, Talcher Kaniha, Korba, Vindhyachal, Dadri, Barh, Solapur, North Karanpura, and Mauda
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
The offer for sale comprises of up to Rs. 383 crore by Vishal Rakesh Agrawal, up to Rs. 383 crore by Rahul Rakesh Agrawal, and up to Rs. 134 crore by Geetganga Investment
The antibacterial market in Oman is worth US $7.5 million, and Elores is looking to capture 0.5 per cent of this segment by year 2025
Glenmark's current portfolio consists of 184 products authorized for distribution in the U.S. marketplace
The survey findings for Delhi-NCR revealed that speech sound disorders exhibit higher prevalence rates in the 6-12 years age group
This is the 166th ANDA out of Eugia Pharma Speciality Group facilities
Subscribe To Our Newsletter & Stay Updated
